Activated protein C resistance: Automated detection of the factor V Leiden mutation by mismatch hybridization

Clinical Chemistry

Volumn 45, Issue 11, 1999, Pages 1925-1931

  Klingler, Karl R ^a   Junold, Thomas ^a   Wielckens, Klaus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; DNA FRAGMENT; PROTEIN C;

ARTICLE; AUTOMATION; BLOOD CLOTTING DISORDER; COST; GENETIC PREDISPOSITION; HUMAN; POINT MUTATION; PROTEIN DEGRADATION; RELIABILITY; THERMOSTABILITY;

EID: 0032712220     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.11.1925     Document Type: Article

References (13)

1. 1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
2. 2. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
3. 3. Zöller B. Familial thrombophilia-resistance to activated protein S deficiency [PhD Thesis]. Malmö, Sweden: University of Lund, Department of Clinical Chemistry, 1996:141 pp.
4. 4. Takamiya O, Ishida F, Kodaira H, Kitano K, APC-resistance and Mnl1 genotype (Gln506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995;73:87-93.
5. 5. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenetic factor of venous thromboembolism. Blood 1995;85:607-14.
6. 6. Hezard N, Cornillet-Lefebvre P, Gillot L, Potron G, Nguyen P. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G→A20210 prothrombin gene and C→T677 MTHFR gene mutations. Thromb Haemost 1998;79:1054-5.
7. 7. Kirschbaum NE, Foster PA. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemost 1995;74:874-8.
8. 8. Bowen DJ, Granville S, Bowley S, Wood N, Bidwell J. Genetic diagnosis of factor V Leiden using heteroduplex technology. Thromb Haemost 1997;77:119-22.
9. 9. Geisel J, Walz T, Bodis M, Quast S, Herrmann W, Fluorescence-based SSCP analysis with automatic allele detection demonstrated for the factor V Leiden mutation. Clin Chem 1998;44: 1986-7.
10. 10. von Ahsen N, Schütz E, Armstrong VW, Oellerich M. Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylentetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 1999;45: 694-6.
11. 11. Erler K. Elecsys® immunoassay systems using electrochemiluminescence detection. Wien Klin Wochenschr l998;110(Suppl 3): 5-10.
12. 12. Klingler KR, Grote S, Holzem G, Wielckens K. Activated protein C (APC)-resistance: automated detection of the point mutation at position 1691 in the factor V gene. Clin Chem Lab Med 1999;37: 101-7.
13. 13. Vandenbroucke JP, Van der Meer FJM, Helmerhorst FM, Rosendaal FR. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Br Med J 1996;313:1127-30.